Amikacin population pharmacokinetics in critically ill Kuwaiti patients.
about
Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumanniiOptimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling.Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies.Population Pharmacokinetics of Amikacin in Adult Patients with Cystic Fibrosis
P2860
Amikacin population pharmacokinetics in critically ill Kuwaiti patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Amikacin population pharmacokinetics in critically ill Kuwaiti patients.
@ast
Amikacin population pharmacokinetics in critically ill Kuwaiti patients.
@en
type
label
Amikacin population pharmacokinetics in critically ill Kuwaiti patients.
@ast
Amikacin population pharmacokinetics in critically ill Kuwaiti patients.
@en
prefLabel
Amikacin population pharmacokinetics in critically ill Kuwaiti patients.
@ast
Amikacin population pharmacokinetics in critically ill Kuwaiti patients.
@en
P2093
P2860
P356
P1476
Amikacin population pharmacokinetics in critically ill Kuwaiti patients.
@en
P2093
Kamal M Matar
Kefaya Abdul-Malek
Roger Jelliffe
Yousef Al-lanqawi
P2860
P304
P356
10.1155/2013/202818
P407
P577
2013-01-30T00:00:00Z